Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

NCT00102141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Postmenopause

Interventions

DRUG: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)
DRUG: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)
DRUG: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)
DRUG: Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)
DRUG: Placebo

Sponsor

Bayer